Q1 results on May 09, 2012

| Updated on November 15, 2017 Published on April 11, 2012

Ranbaxy Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 09, 2012, inter-alia, to consider Standalone and Consolidated Unaudited Financial Results for the quarter ended March 31, 2012 as reviewed by the Statutory Auditors of the Company.

Source : BSE - >

Published on April 11, 2012
This article is closed for comments.
Please Email the Editor